Historically, sedating antihistamines such as hydroxyzine and doxepin have been used to treat psoriatic itch. They may have some role in treating nocturnal itch; however, their antipruritic efficacy ...

Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%. Findings indicated ...

Please provide your email address to receive an email when new articles are posted on . Patient reported data from two phase 3 trials found roflumilast cream 0.3% significantly reduced itch severity ...

You notice a scaly, itchy rash on your skin and immediately start wondering what’s causing it. Two common culprits that can look surprisingly similar are psoriasis and ringworm, but getting the right ...

Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...

More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...

Psoriasis, with its patches of itchy, flaky skin, is often nothing more than a benign cosmetic problem. Yet, for many people, it’s as disabling and threatening as rheumatoid arthritis or cancer. These ...

Psoriasis is a common inflammatory skin disease linked to several long-term health conditions, such as heart disease, ...

Topical or oral corticosteroids generally cost $10 to $20 a month.

Itch is an important, but underestimated symptom in psoriasis. Many therapies are available for pruritus; however, few are effective for psoriatic itch. Antipruritic therapies that are potentially ...